Estimating the proportion cured of cancer: Some practical advice for users

Cancer Epidemiology

Volumn 37, Issue 6, 2013, Pages 836-842

  Yu, X Q ^a,b   De Angelis, R ^c   Andersson, T M L ^d   Lambert, P C ^d,e   O'Connell, D L ^a,b,f,g   Dickman, P W ^d  

^a CANCER RESEARCH DIVISION   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF LEICESTER   (United Kingdom)

^f UNIVERSITY OF NEWCASTLE   (Australia)

^g UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cure models; Population based; Relative survival; Statistical cure

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CANCER SURVIVOR; COLON CANCER; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MODEL; OVARY CANCER; PRIORITY JOURNAL;

CURE MODELS; POPULATION-BASED; RELATIVE SURVIVAL; STATISTICAL CURE;

AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; MODELS, STATISTICAL; MORTALITY; OVARIAN NEOPLASMS; PROGNOSIS; REGISTRIES; SURVIVAL RATE;

EID: 84888294950     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.08.014     Document Type: Article

References (31)

1. Dickman P.W., Adami H.O. Interpreting trends in cancer patient survival. J Intern Med 2006, 260:103-117.
2. Yu B., Tiwari R.C., Cronin K.A., McDonald C., Feuer E.J. CANSURV: A Windows program for population-based cancer survival analysis. Comput Methods Programs Biomed 2005, 80:195-203.
3. Verdecchia A., De Angelis R., Capocaccia R., et al. The cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998, 77:322-329.
4. De Angelis R., Capocaccia R., Hakulinen T., Soderman B., Verdecchia A. Mixture models for cancer survival analysis: application to population-based data with covariates. Stat Med 1999, 18:441-454.
5. Lambert P.C., Thompson J.R., Weston C.L., Dickman P.W. Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 2007, 8:576-594.
6. Andersson T.M., Dickman P.W., Eloranta S., Lambert P.C. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models. BMC Med Res Methodol 2011, 11:96.
7. Andersson T.M., Lambert P.C., Derolf A.R., Kristinsson S.Y., Eloranta S., Landgren O. Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study. Br J Haematol 2010, 148:918-924.
8. Clements M.S., Roder D.M., Yu X.Q., Egger S., O'Connell D.L. Estimating prevalence of distant metastatic breast cancer: a means of filling a data gap. Cancer Causes Control 2012, 23:1625-1634.
9. Eloranta S., Lambert P.C., Cavalli-Bjorkman N., Andersson T.M., Glimelius B., Dickman P.W. Does socioeconomic status influence the prospect of cure from colon cancer - a population-based study in Sweden 1965-2000. Eur J Cancer 2010, 46:2965-2972.
10. Lambert P.C., Dickman P.W., Osterlund P., Andersson T., Sankila R., Glimelius B. Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry. Int J Cancer 2007, 121:2052-2059.
11. Woods L.M., Rachet B., Lambert P.C., Coleman M.P. 'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis. Ann Oncol 2009, 20:1331-1336.
12. SEER Surveillance Epidemiology and End Results (SEER) Program Research Data (1973-2007) National Cancer Institute, DCCPS, Surveillance Research Program Cancer Statistics Branch 2010, National Cancer Institute, Released April 2010, based on the November 2009 submission.
13. Cansurv. Statistical Methodology Applications Branch 2005, National Cancer Institute, Version 1. 0. Data Modeling Branch (Ed.).
14. Ederer F., Heise H. Instructions to IMB 650 Programmers in Processing Survival Computations Methodological note No. 10. End Results Evaluation Sectioned 1959, National Cancer Institute, Bethesda.
15. Lambert P.C., Dickman P.W., Weston C.L., Thompson J.R. Estimating the cure fraction in population-based cancer studies using finite mixture models. J Roy Statist Soc 2010, 59:35-55.
16. Maller R.A., Zhou S. Testing for the presence of immune or cured individuals in censored survival data. Biometrics 1995, 51:1197-1205.
17. Peng Y., Dear K.B., Carriere K.C. Testing for the presence of cured patients: a simulation study. Stat Med 2001, 20:1783-1796.
18. Othus M., Barlogie B., Leblanc M.L., Crowley J.J. Cure models as a useful statistical tool for analyzing survival. Clin Cancer Res 2012, 18:3731-3736.
19. Othus M., Li Y., Tiwari R. Change point-cure models with application to estimating the change-point effect of age of diagnosis among prostate cancer patients. J Appl Stat 2012, 39:901-911.
20. Rondeau V., Schaffner E., Corbiere F., Gonzalez J.R., Mathoulin-Pelissier S. Cure frailty models for survival data: application to recurrences for breast cancer and to hospital readmissions for colorectal cancer. Stat Methods Med Res 2013, 22:243-260.
21. Tai P., Yu E., Cserni G., et al. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database. BMC Cancer 2005, 5:48.
22. Wichmann M.W., Muller C., Hornung H.M., Lau-Werner U., Schildberg F.W. Results of long-term follow-up after curative resection of Dukes A colorectal cancer. World J Surg 2002, 26:732-736.
23. Wilkinson N.W., Yothers G., Lopa S., Costantino J.P., Petrelli N.J., Wolmark N. Long-term survival results of surgery alone versus surgery plus 5-fluorouracil and leucovorin for stage II and stage III colon cancer: pooled analysis of NSABP C-01 through C-05. A baseline from which to compare modern adjuvant trials. Ann Surg Oncol 2010, 17:959-966.
24. Gallagher D.J., Kemeny N. Metastatic colorectal cancer: from improved survival to potential cure. Oncology 2010, 78:237-248.
25. Tomlinson J.S., Jarnagin W.R., DeMatteo R.P., et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007, 25:4575-4580.
26. Jelovac D., Armstrong D.K. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 2011, 61:183-203.
27. Swenerton K.D., Santos J.L., Gilks C.B., et al. Histotype predicts the curative potential of radiotherapy: the example of ovarian cancers. Ann Oncol 2011, 22:341-347.
28. Cvancarova M., Aagnes B., Fossa S.D., Lambert P.C., Moller B., Bray F. Proportion cured models applied to 23 cancer sites in Norway. Int J Cancer 2013, 132:1700-1710.
29. Mallett S., Royston P., Waters R., Dutton S., Altman D.G. Reporting performance of prognostic models in cancer: a review. BMC Med 2010, 8:21.
30. Andersson T.M.L., Lambert P.C. Fitting and modeling cure in population-based cancer studies within the framework of flexible parametric survival models. Stata J 2012, 12:623-638.
31. Lambert P.C., Royston P. Further development of flexible parametric models for survival analysis. Stata J 2009, 9:265-290.